News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI Thinks Like Us – Flaws and All: New Study Finds ChatGPT Mirrors Human Decision Biases in Half the Tests
News Release

BALTIMORE, MD, April 1, 2025 – Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations showing biases like overconfidence of hot-hand (gambler’s) fallacy yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).

Read More
In 2025, you can’t have an effective democracy without data literacy
Media Coverage

You are swimming in an ocean of data and don’t even realize it. All around you are invisible amounts of data that would be staggering to try to comprehend. Thousands of smartphones and smart devices are talking to, sending and downloading vast amounts of data, video, audio, words, numbers, images, you name it. Everything from the latest movie on Netflix to someone’s radiology results from a cancer screening.

Read More
Shell Shocked: How Small Eateries Are Dealing With Record Egg Prices
Media Coverage

Mom-and-pop businesses are trying to adapt to the soaring cost of eggs. The owners of four egg-centric restaurants across the country show how they are coping with this threat to their livelihoods.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Controlling the Spread of Coronavirus Via Repeat Testing and Isolation

Controlling the Spread of Coronavirus Via Repeat Testing and Isolation

Significance, November 25, 2020

What to do about Covid? With nearly 60 million cases and 1.4 million deaths worldwide as of the end of November 2020, there are still no consistently effective treatments or approved vaccines yet (though large-scale vaccine trials have already produced promising results). Social distancing, mask wearing, and infection control practices can reduce the rate of spread somewhat, but as long as infectious individuals circulate amongst susceptible persons, continued spread is inevitable, given that most populations have not built immunity against SARS-CoV-2 to any meaningful extent.

Don't Count on Finding Toilet Paper on  Your Next Run to Target or Walmart: COVID-19 Panic Buying is on a Roll Again

Don't Count on Finding Toilet Paper on Your Next Run to Target or Walmart: COVID-19 Panic Buying is on a Roll Again

USA Today, November 23, 2020

Paper products and other household staples are in high demand in stores and online again as the virus surges and lockdowns loom, but none more so than those essential rolls of soft cotton squares. Photos of bare shelves and public pleas to leave behind a few rolls for other shoppers are overflowing social media. “The toilet paper aisle is CLEARED!” one person wrote on Twitter. “March 2.0 is here folkssss.”

5 Ways to Strengthen Your Supply Chains

5 Ways to Strengthen Your Supply Chains

Bank of American, November 23, 2020

The coronavirus revealed stark vulnerabilities in the supply chains that move products from the raw material stage, through production, and to a customer’s door. As key segments of this system faltered, businesses responded in real time, finding new ways to source materials and keep their products moving. The lessons learned from this experience can help companies transform how they view and build supply chains, says Matthew Elliott, Business Banking Midwest Region Executive for Bank of America.

Some Companies Will Make Big Money Off Their COVID-19 Vaccines - But Not as Much as They Could

Some Companies Will Make Big Money Off Their COVID-19 Vaccines - But Not as Much as They Could

CBC, November 25, 2020

While the development of a COVID-19 vaccine could generate billions of dollars for some pharmaceutical companies such as Pfizer, concerns over accusations of exploiting the pandemic will likely temper profits, experts suggest. "It doesn't really make sense to profit from this pandemic," said Tinglong Dai, associate professor of operations management and business analytics at Johns Hopkins University Carey Business School in Baltimore.

What's the Science Behind COVID Business Capacity Limits?

What's the Science Behind COVID Business Capacity Limits?

Las Vegas Review-Journal, November 25, 2020

New restrictions imposed on restaurants and other businesses this week by Gov. Steve Sisolak to curb the spread of COVID-19 raise a question: What’s the science behind them? The science is imperfect, broad in stroke and balanced by policy and political considerations, health authorities said. “The basic idea is we are trying to reduce the density of people in any environment,” said epidemiologist Brian Labus, a member of the governor’s medical advisory team on COVID-19.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine